×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| UNICHEM LABORATORIES LTD. | 5,467.10 | 578.50 | 5,330.90 | 8.19 | 4,850 | 57.3 |
| Orchid Pharma Limited | 2272.8 | 239.06 | 2173.43 | 4.71 | 4657 | 42.2 |
| HIKAL LTD. | 4,513.00 | 172.00 | 4,477.00 | 1.39 | 4410 | 59.2 |
Unichem Laboratories Ltd.,, with Security Code 506690, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 244.7 | 265.6 | 251.9 | 310.0 | 346.6 | 333.8 | 362.4 | 399.2 | 389.7 | 436.8 |
| Expenses | 255.7 | 296.8 | 294.1 | 318.8 | 338.4 | 341.1 | 343.1 | 368.6 | 349.5 | 372.4 |
| Operating Profit | -10.9 | -31.1 | -42.2 | -8.7 | 8.3 | -7.3 | 19.3 | 30.6 | 40.2 | 64.5 |
| OPM % | -4.45% | -11.72% | -16.73% | -2.82% | 2.4% | -2.19% | 5.33% | 7.66% | 10.31% | 14.76% |
| Other Income | 11.8 | 5.8 | 15.4 | -103.9 | 5.8 | 7.6 | 78.0 | -118.6 | 8.8 | 7.1 |
| Interest | 1.7 | 3.0 | 1.8 | 2.9 | 2.5 | 3.8 | 2.4 | 1.8 | 1.4 | 1.8 |
| Depreciation | 22.6 | 26.5 | 28.6 | 28.3 | 27.4 | 27.3 | 25.6 | 25.2 | 26.1 | 26.4 |
| Profit before tax | -23.3 | -49.8 | -57.1 | -36.2 | -15.7 | -30.8 | 1.3 | 10.7 | 21.5 | 43.4 |
| Tax % | 0% | -37.6% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -23.3 | -75.5 | -57.1 | -143.8 | -15.7 | -30.8 | 69.3 | -115.0 | 21.5 | 43.4 |
| EPS in Rs | -3.31 | -10.72 | -8.11 | -20.43 | -2.23 | -4.38 | 9.85 | -16.33 | 3.04 | 6.15 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 328.8 | 302.5 | 402.1 | 423.2 | 415.6 | 434.4 | 431.7 | 446.4 | 462.2 | 533.1 |
| Expenses | 347.1 | 345.3 | 385.6 | 395.2 | 406.9 | 396.3 | 406.4 | 402.9 | 404.6 | 447.6 |
| Operating Profit | -18.3 | -42.8 | 16.5 | 28.0 | 8.8 | 38.1 | 25.4 | 43.5 | 57.5 | 85.5 |
| OPM % | -5.6% | -14.1% | 4.1% | 6.6% | 2.1% | 8.8% | 5.9% | 9.7% | 12.4% | 16% |
| Other Income | 4.2 | 16.4 | -28.4 | 8.6 | 5.5 | 79.3 | -119.5 | 3.9 | 8.8 | 13.6 |
| Interest | 4.7 | 4.1 | 5.5 | 5.8 | 6.7 | 5.6 | 4.6 | 4.0 | 4.8 | 6.8 |
| Depreciation | 28.4 | 30.8 | 29.7 | 28.8 | 29.5 | 27.9 | 27.2 | 28.3 | 28.5 | 30.5 |
| Profit before tax | -42.2 | -61.3 | -13.6 | 2.1 | -21.9 | 16.0 | -0.2 | 15.0 | 33.0 | 61.9 |
| Tax % | -49.5% | -4.3% | -6.1% | 131.6% | -11.9% | 0% | -2.7% | 38.3% | 7.6% | 6.5% |
| Net Profit | -70.7 | -63.9 | -44.3 | -0.7 | -24.5 | 84.0 | -129.3 | 9.3 | 30.5 | 57.9 |
| EPS in Rs | -10 | -9 | -6 | 0 | -3 | 11 | -18 | 1 | 4 | 8 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 8% |
| 3 Years: | 9% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 250% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 39% |
| 3 Years: | 41% |
| 1 Year: | 29% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 8% |
| 3 Years: | 11% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 6% |
| 3 Years: | 0% |
| TTM: | 376% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 39% |
| 3 Years: | 41% |
| 1 Year: | 29% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|